Annual Retained Earnings
-$1.91 B
-$110.56 M-6.16%
31 December 2023
Summary:
Heron Therapeutics annual retained earnings is currently -$1.91 billion, with the most recent change of -$110.56 million (-6.16%) on 31 December 2023. During the last 3 years, it has fallen by -$513.27 million (-36.85%). HRTX annual retained earnings is now -19549.63% below its all-time high of -$9.70 million, reached on 31 December 1987.HRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.92 B
-$4.85 M-0.25%
30 September 2024
Summary:
Heron Therapeutics quarterly retained earnings is currently -$1.92 billion, with the most recent change of -$4.85 million (-0.25%) on 30 September 2024. Over the past year, it has dropped by -$27.97 million (-1.48%). HRTX quarterly retained earnings is now -19727.39% below its all-time high of -$9.70 million, reached on 31 December 1987.HRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.2% | -1.5% |
| 3 y3 years | -36.9% | -23.4% |
| 5 y5 years | -98.4% | -73.7% |
HRTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.9% | at low | -23.4% | at low |
| 5 y | 5 years | -98.4% | at low | -73.7% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Heron Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.92 B(+0.3%) |
| June 2024 | - | -$1.92 B(+0.5%) |
| Mar 2024 | - | -$1.91 B(+0.2%) |
| Dec 2023 | -$1.91 B(+6.2%) | -$1.91 B(+0.6%) |
| Sept 2023 | - | -$1.90 B(+1.3%) |
| June 2023 | - | -$1.87 B(+2.3%) |
| Mar 2023 | - | -$1.83 B(+1.8%) |
| Dec 2022 | -$1.80 B(+11.3%) | -$1.80 B(+1.1%) |
| Sept 2022 | - | -$1.78 B(+2.4%) |
| June 2022 | - | -$1.73 B(+3.4%) |
| Mar 2022 | - | -$1.68 B(+4.0%) |
| Dec 2021 | -$1.61 B(+15.8%) | -$1.61 B(+3.5%) |
| Sept 2021 | - | -$1.56 B(+3.5%) |
| June 2021 | - | -$1.51 B(+4.2%) |
| Mar 2021 | - | -$1.45 B(+3.8%) |
| Dec 2020 | -$1.39 B(+19.5%) | -$1.39 B(+4.7%) |
| Sept 2020 | - | -$1.33 B(+4.6%) |
| June 2020 | - | -$1.27 B(+4.5%) |
| Mar 2020 | - | -$1.22 B(+4.4%) |
| Dec 2019 | -$1.17 B(+21.3%) | -$1.17 B(+5.2%) |
| Sept 2019 | - | -$1.11 B(+3.1%) |
| June 2019 | - | -$1.07 B(+4.9%) |
| Mar 2019 | - | -$1.02 B(+6.6%) |
| Dec 2018 | -$960.72 M(+22.6%) | -$960.72 M(+5.4%) |
| Sept 2018 | - | -$911.16 M(+4.4%) |
| June 2018 | - | -$872.82 M(+4.6%) |
| Mar 2018 | - | -$834.15 M(+6.5%) |
| Dec 2017 | -$783.46 M(+33.7%) | -$783.46 M(+8.7%) |
| Sept 2017 | - | -$720.97 M(+6.2%) |
| June 2017 | - | -$679.10 M(+6.7%) |
| Mar 2017 | - | -$636.30 M(+8.6%) |
| Dec 2016 | -$585.97 M(+41.9%) | -$585.97 M(+8.9%) |
| Sept 2016 | - | -$538.01 M(+9.9%) |
| June 2016 | - | -$489.50 M(+9.7%) |
| Mar 2016 | - | -$446.27 M(+8.1%) |
| Dec 2015 | -$412.83 M(+31.0%) | -$412.83 M(+8.2%) |
| Sept 2015 | - | -$381.59 M(+6.3%) |
| June 2015 | - | -$358.91 M(+6.9%) |
| Mar 2015 | - | -$335.81 M(+6.5%) |
| Dec 2014 | -$315.24 M(+32.0%) | -$315.24 M(+7.0%) |
| Sept 2014 | - | -$294.61 M(+7.0%) |
| June 2014 | - | -$275.42 M(+7.4%) |
| Mar 2014 | - | -$256.41 M(+7.3%) |
| Dec 2013 | -$238.87 M(+30.1%) | -$238.87 M(+6.2%) |
| Sept 2013 | - | -$224.83 M(+6.1%) |
| June 2013 | - | -$211.95 M(+7.8%) |
| Mar 2013 | - | -$196.54 M(+7.1%) |
| Dec 2012 | -$183.59 M(+14.6%) | -$183.59 M(+4.4%) |
| Sept 2012 | - | -$175.85 M(+3.6%) |
| June 2012 | - | -$169.73 M(+2.8%) |
| Mar 2012 | - | -$165.16 M(+3.1%) |
| Dec 2011 | -$160.24 M(+8.0%) | -$160.24 M(+2.7%) |
| Sept 2011 | - | -$155.98 M(+2.8%) |
| June 2011 | - | -$151.78 M(+1.3%) |
| Mar 2011 | - | -$149.84 M(+1.0%) |
| Dec 2010 | -$148.43 M(+5.2%) | -$148.43 M(+1.1%) |
| Sept 2010 | - | -$146.83 M(+1.2%) |
| June 2010 | - | -$145.16 M(+2.5%) |
| Mar 2010 | - | -$141.57 M(+0.4%) |
| Dec 2009 | -$141.08 M(+7.7%) | -$141.08 M(+1.4%) |
| Sept 2009 | - | -$139.17 M(+0.9%) |
| June 2009 | - | -$137.95 M(+2.9%) |
| Mar 2009 | - | -$134.01 M(+2.3%) |
| Dec 2008 | -$131.05 M(+21.4%) | -$131.05 M(+3.1%) |
| Sept 2008 | - | -$127.11 M(+5.1%) |
| June 2008 | - | -$120.90 M(+5.3%) |
| Mar 2008 | - | -$114.77 M(+6.3%) |
| Dec 2007 | -$107.93 M(+23.0%) | -$107.93 M(+7.7%) |
| Sept 2007 | - | -$100.23 M(+4.9%) |
| June 2007 | - | -$95.54 M(+1.9%) |
| Mar 2007 | - | -$93.77 M(+6.8%) |
| Dec 2006 | -$87.76 M | -$87.76 M(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | -$82.10 M(+4.9%) |
| June 2006 | - | -$78.28 M(+6.2%) |
| Mar 2006 | - | -$73.73 M(-20.7%) |
| Dec 2005 | -$93.03 M(+9.7%) | -$93.03 M(+2.9%) |
| Sept 2005 | - | -$90.43 M(+2.0%) |
| June 2005 | - | -$88.68 M(+3.0%) |
| Mar 2005 | - | -$86.08 M(+1.5%) |
| Dec 2004 | -$84.82 M(+12.2%) | -$84.82 M(+2.7%) |
| Sept 2004 | - | -$82.56 M(+2.4%) |
| June 2004 | - | -$80.64 M(+3.1%) |
| Mar 2004 | - | -$78.20 M(+3.4%) |
| Dec 2003 | -$75.60 M(+6.1%) | -$75.60 M(+1.9%) |
| Sept 2003 | - | -$74.22 M(+1.4%) |
| June 2003 | - | -$73.16 M(+2.8%) |
| Mar 2003 | - | -$71.20 M(-0.0%) |
| Dec 2002 | -$71.23 M(+5.6%) | -$71.23 M(+0.3%) |
| Sept 2002 | - | -$71.01 M(+1.5%) |
| June 2002 | - | -$69.95 M(+2.2%) |
| Mar 2002 | - | -$68.46 M(+1.5%) |
| Dec 2001 | -$67.46 M(+3.9%) | -$67.46 M(+2.6%) |
| Sept 2001 | - | -$65.77 M(-2.2%) |
| June 2001 | - | -$67.26 M(+1.8%) |
| Mar 2001 | - | -$66.06 M(+1.7%) |
| Dec 2000 | -$64.94 M(-11.6%) | -$64.94 M(+2.5%) |
| Sept 2000 | - | -$63.35 M(-14.3%) |
| June 2000 | - | -$73.91 M(+0.9%) |
| Mar 2000 | - | -$73.27 M(-0.3%) |
| Dec 1999 | -$73.50 M(-3.2%) | -$73.50 M(-1.7%) |
| Sept 1999 | - | -$74.80 M(+7.3%) |
| June 1999 | - | -$69.70 M(-0.4%) |
| Mar 1999 | - | -$70.00 M(-7.8%) |
| Dec 1998 | -$75.90 M(+5.0%) | -$75.90 M(+6.2%) |
| Sept 1998 | - | -$71.50 M(-0.7%) |
| June 1998 | - | -$72.00 M(-0.3%) |
| Mar 1998 | - | -$72.20 M(-0.1%) |
| Dec 1997 | -$72.30 M(+1.0%) | -$72.30 M(+0.1%) |
| Sept 1997 | - | -$72.20 M(+0.6%) |
| June 1997 | - | -$71.80 M(+0.8%) |
| Mar 1997 | - | -$71.20 M(-0.6%) |
| Dec 1996 | -$71.60 M(+15.1%) | -$71.60 M(+4.7%) |
| Sept 1996 | - | -$68.40 M(+3.2%) |
| June 1996 | - | -$66.30 M(+3.3%) |
| Mar 1996 | - | -$64.20 M(+3.2%) |
| Dec 1995 | -$62.20 M(+17.8%) | -$62.20 M(+7.8%) |
| Sept 1995 | - | -$57.70 M(+3.6%) |
| June 1995 | - | -$55.70 M(+3.5%) |
| Mar 1995 | - | -$53.80 M(+1.9%) |
| Dec 1994 | -$52.80 M(+22.8%) | -$52.80 M(+4.8%) |
| Sept 1994 | - | -$50.40 M(+5.7%) |
| June 1994 | - | -$47.70 M(+6.2%) |
| Mar 1994 | - | -$44.90 M(+4.4%) |
| Dec 1993 | -$43.00 M(+30.3%) | -$43.00 M(+7.5%) |
| Sept 1993 | - | -$40.00 M(+7.0%) |
| June 1993 | - | -$37.40 M(+7.5%) |
| Mar 1993 | - | -$34.80 M(+5.5%) |
| Dec 1992 | -$33.00 M(+20.4%) | -$33.00 M(+5.8%) |
| Sept 1992 | - | -$31.20 M(+3.0%) |
| June 1992 | - | -$30.30 M(+3.4%) |
| Mar 1992 | - | -$29.30 M(+6.9%) |
| Dec 1991 | -$27.40 M(+18.6%) | -$27.40 M(+5.8%) |
| Sept 1991 | - | -$25.90 M(+4.4%) |
| June 1991 | - | -$24.80 M(+2.1%) |
| Mar 1991 | - | -$24.30 M(+5.2%) |
| Dec 1990 | -$23.10 M(+20.3%) | -$23.10 M(+2.7%) |
| Sept 1990 | - | -$22.50 M(+5.6%) |
| June 1990 | - | -$21.30 M(+6.0%) |
| Mar 1990 | - | -$20.10 M(+4.7%) |
| Dec 1989 | -$19.20 M(+30.6%) | -$19.20 M(+6.1%) |
| Sept 1989 | - | -$18.10 M(+5.2%) |
| June 1989 | - | -$17.20 M(+17.0%) |
| Dec 1988 | -$14.70 M(+51.5%) | -$14.70 M(+51.5%) |
| Dec 1987 | -$9.70 M | -$9.70 M |
FAQ
- What is Heron Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Heron Therapeutics?
- What is Heron Therapeutics annual retained earnings year-on-year change?
- What is Heron Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Heron Therapeutics?
- What is Heron Therapeutics quarterly retained earnings year-on-year change?
What is Heron Therapeutics annual retained earnings?
The current annual retained earnings of HRTX is -$1.91 B
What is the all time high annual retained earnings for Heron Therapeutics?
Heron Therapeutics all-time high annual retained earnings is -$9.70 M
What is Heron Therapeutics annual retained earnings year-on-year change?
Over the past year, HRTX annual retained earnings has changed by -$110.56 M (-6.16%)
What is Heron Therapeutics quarterly retained earnings?
The current quarterly retained earnings of HRTX is -$1.92 B
What is the all time high quarterly retained earnings for Heron Therapeutics?
Heron Therapeutics all-time high quarterly retained earnings is -$9.70 M
What is Heron Therapeutics quarterly retained earnings year-on-year change?
Over the past year, HRTX quarterly retained earnings has changed by -$27.97 M (-1.48%)